Literature DB >> 7750506

Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants.

C L Zhang1, J P Dreier, U Heinemann.   

Abstract

Lowering of extracellular Mg2+ results in various forms of epileptiform activity in different parts of temporal lobe slices [5,22] which contain neocortical areas such as areas Te2 or Te3, the entorhinal cortex (EC), subiculum, hippocampal areas CA1 to CA3 and the dentate gyrus [5,11]. In the EC, the subiculum and Te2/Te3 seizure-like events (SLEs) with tonic and clonic electrographic discharge patterns, negative slow field potentials and ionic changes comparable to those during tonic-clonic seizures in intact animals were observed. After 30 to 120 min of recurrent seizure activity (80 +/- 37 min) the seizure-like events (SLEs) developed into a state of late recurrent discharges (LRDs). Since previous studies had shown that the LRDs do not respond to valproic acid in contrast to a blocking effect of this drug on SLEs, we investigated the effects of the clinically employed anticonvulsants phenytoin, carbamazepine, phenobarbital, midazolam and ethosuximide on LRDs. All these agents were unable to block the LRDs in the EC, subiculum and Te2/Te3. This was found true both for concentrations which can block SLEs and for higher concentrations. Thus we conclude that this activity may represent a model of difficult to treat status epilepticus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750506     DOI: 10.1016/0920-1211(94)00067-7

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  20 in total

1.  Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus.

Authors:  Richard J Burman; Joshua S Selfe; John Hamin Lee; Maurits van den Berg; Alexandru Calin; Neela K Codadu; Rebecca Wright; Sarah E Newey; R Ryley Parrish; Arieh A Katz; Jo M Wilmshurst; Colin J Akerman; Andrew J Trevelyan; Joseph V Raimondo
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

2.  Surface charge impact in low-magnesium model of seizure in rat hippocampus.

Authors:  Dmytro Isaev; Gleb Ivanchick; Volodymyr Khmyz; Elena Isaeva; Alina Savrasova; Oleg Krishtal; Gregory L Holmes; Oleksandr Maximyuk
Journal:  J Neurophysiol       Date:  2011-10-26       Impact factor: 2.714

3.  Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro.

Authors:  M Pfeiffer; A Draguhn; H Meierkord; U Heinemann
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 4.  Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier.

Authors:  Damir Janigro
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

Review 5.  Issues related to development of new antiseizure treatments.

Authors:  Karen S Wilcox; Tracy Dixon-Salazar; Graeme J Sills; Elinor Ben-Menachem; H Steve White; Roger J Porter; Marc A Dichter; Solomon L Moshé; Jeffrey L Noebels; Michael D Privitera; Michael A Rogawski
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

6.  Transition to seizures in the isolated immature mouse hippocampus: a switch from dominant phasic inhibition to dominant phasic excitation.

Authors:  M Derchansky; S S Jahromi; M Mamani; D S Shin; A Sik; P L Carlen
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

Review 7.  Comparison of the effects of serotonin in the hippocampus and the entorhinal cortex.

Authors:  D Schmitz; T Gloveli; R M Empson; U Heinemann
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

8.  Antiepileptic drugs abolish ictal but not interictal epileptiform discharges in vitro.

Authors:  Margherita D'Antuono; Rüdiger Köhling; Serena Ricalzone; Jean Gotman; Giuseppe Biagini; Massimo Avoli
Journal:  Epilepsia       Date:  2009-08-19       Impact factor: 5.864

Review 9.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 10.  Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures.

Authors:  Tarek Z Deeb; Jamie Maguire; Stephen J Moss
Journal:  Epilepsia       Date:  2012-12       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.